- NEWS
China’s zero-COVID strategy: what happens next?
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
24,99 € / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
204,58 € per year
only 4,01 € per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 602, 15-16 (2022)
doi: https://doi.org/10.1038/d41586-022-00191-7
Omicron is supercharging the COVID vaccine booster debate
China’s COVID vaccines are going global — but questions remain